No Data
No Data
Aurisco Pharmaceutical (605116.SH): "Aurisco Convertible Bonds" will be listed for trading on the Shanghai Stock Exchange starting from August 15th.
Aurisco Pharmaceutical (605116.SH) released an announcement that its 0.812 billion yuan convertible corporate bonds will mature in 2024 and...
Aurisco Pharmaceutical Co.,Ltd. (SHSE:605116) Adds CN¥463m in Market Cap and Insiders Have a 76% Stake in That Gain
Aurisco Pharmaceutical (605116.SH): The active pharmaceutical ingredient for telaprevir is still in the early stage of development.
Aurisco Pharmaceutical (605116.SH) stated on the investor interaction platform on July 26 that the company's active pharmaceutical ingredient for Terlipressin is still in the early stage of development.
Aurisco Pharmaceutical (605116.SH): "Aurisco Convertible Bonds" will be available for subscription on July 26th.
Aurisco Pharmaceutical (605116.SH) announced that the company will issue convertible bonds worth 0.812 billion yuan ("Convertible Bonds")...
There's Reason For Concern Over Aurisco Pharmaceutical Co.,Ltd.'s (SHSE:605116) Price
Announcement of aurisco pharmaceutical's expected performance increase in the first half of 2024.
No Data